Skip to content

Facebook Twitter Linkedin

Pharmaceutical
Manufacturing
Investors
Corporate
Learn

Menu

Pharmaceutical
Manufacturing
Investors
Corporate
Learn

Investor Relations

Latest News

InMed Announces Publication of Peer-Reviewed Study Showing the Anti-Inflammatory Potential of Rare Cannabinoids in Skin Conditions

March 13, 2023

InMed to Participate in Upcoming Investor Events

March 6, 2023

InMed Reports Second Quarter Fiscal 2023 Financial Results and Provides Business Update

February 17, 2023

InMed Submits Form 12b-25

February 9, 2023

Latest Events

VirtualInvestorConferences.com – Life Sciences Investor Forum

March 3, 2023

Emerging Growth Conference

March 3, 2023

Tribe Public’s Webinar Event “Exploring the Neuroprotective Qualities of Rare Cannabinoids”

November 10, 2022

Force For Knowledge Cannabis Symposium – Jump Starting Cannabis Valuations 101

June 27, 2022

Stock Information

NASDAQ:INM stock price by TradingView

See Stock Information

Presentations

Corporate Presentation – March 2023

View Presentation

View All Presentations

Latest Financial Reports

2023

Q1

Quarterly Press Release

Q2

Quarterly Press Release

Financial Statements

MD&A

View All Financial Reports

Latest SEC Filings

Investor Alerts

Sign up for investor alerts!

Information Request

Send us a request for information

#310 – 815 West Hastings St.
Vancouver, BC, Canada
V6C 1B4

Pharmaceutical

Cannabinoids in Development
INM-755 for Epidermolysis Bullosa
INM-088 for Glaucoma
Neurodegenerative Disease
Novel Cannabinoid Analogs

MANUFACTURING

Cannabinoid Manufacturing Expertise
IntegraSyn™ Cannabinoid Manufacturing
BayMedica Cannabinoid Biosynthesis
Rare Cannabinoid Ingredients

Investor

News
Events
Stock Information
Corporate Governance
Financials & AGM
Filings
Presentations
Media

CORPORATE

Management
Board of Directors
Scientific Advisory Board
Partners and Collaborators
Careers
Contact

Learn

What is Cannabinol (CBN)?
What is Epidermolysis Bullosa (EB)?
What is Glaucoma?
Cannabinoid Manufacturing Economics 101
GMP Manufacturing Standards by Product Type
Cannabinoids for Glaucoma
Cannabinoid Science
Articles and Videos

© Copyright 2023 InMed Pharmaceuticals Inc.

Privacy Policy
Terms of Use
Legal Disclaimer

Find Us On:

Sign up to receive emails from InMed Pharmaceuticals

"*" indicates required fields

Name*

First name* Last name*

Email*

Consent

By providing your e-mail address, you consent to receive news, press releases, quarterly and annual reports, presentations and other information from InMed Pharmaceuticals Inc. You can unsubscribe at any time.